Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

Major Program
Phase 0 I II Cancer Prevention Clinical Trials Program
Research Group
Gastrointestinal and Other Cancers
National Cancer Institute (NCI)
Active, not recruiting ID
For more information, see NCT03278925
This phase I trial studies the side effects and best dose of defined green tea catechin
extract and to see how well it works in preventing liver cancer in participants with
cirrhosis. Higher levels of the molecule gamma-OHPdG may be found in participants with
cirrhosis, which may mean a higher risk of the development of liver cancer. Defined green tea
catechin extract may work better to lower levels of gamma-OHPdG and prevent the development
of liver cancer.
Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration
Aiwu R He

See list of participating sites